Performance Evaluation of the Microfluidic Antigen LumiraDx SARS-CoV-2 and FluĀ A/B Test in Diagnosing COVID-19 and Influenza in Patients with Respiratory Symptoms
Crossref DOI link: https://doi.org/10.1007/s40121-022-00696-8
Published Online: 2022-09-24
Published Print: 2022-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ellis, Jayne E.
Guest, Poppy
Lawson, Vicki
Loecherbach, Julia
Lindner, Nigel
McCulloch, Andrew
Funding for this research was provided by:
LumirDx
Text and Data Mining valid from 2022-09-24
Version of Record valid from 2022-09-24
Article History
Received: 20 July 2022
Accepted: 7 September 2022
First Online: 24 September 2022